Antihypertensive pharmacogenetic effect of fibrinogen-beta variant-455G>A on cardiovascular disease, end-stage renal disease, and mortality: The GenHAT study
- Amy I. Lynch
- , Eric Boerwinkle
- , Barry R. Davis
- , Charles E. Ford
- , John H. Eckfeldt
- , Catherine Leiendecker-Foster
- , Donna K. Arnett
Producción científica: Article › revisión exhaustiva
19
Citas
(Scopus)